Publicaciones en colaboración con investigadores/as de Necker-Enfants Malades Hospital (17)

2020

  1. BCG Moreau Vaccine Safety Profile and NK Cells—Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency

    Journal of Clinical Immunology, Vol. 40, Núm. 1, pp. 138-146

  2. Successful Preclinical Development of Gene Therapy for Recombinase-Activating Gene-1-Deficient SCID

    Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 666-682

2018

  1. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia

    Leukemia, Vol. 32, Núm. 4, pp. 874-881

2014

  1. Successful RAG1-SCID gene therapy depends on the level of RAG1 expression

    Journal of Allergy and Clinical Immunology

2013

  1. The MLL recombinome of acute leukemias in 2013

    Leukemia, Vol. 27, Núm. 11, pp. 2165-2176

2012

  1. Capillary electrophoresis single-strand conformation analysis (CE-SSCA) for clonality detection in lymphoproliferative disorders

    Journal of Hematopathology, Vol. 5, Núm. 1-2, pp. 83-89

  2. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    Leukemia, Vol. 26, Núm. 10, pp. 2159-2171

2010

  1. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: A European MCL intergroup study

    Blood, Vol. 115, Núm. 16, pp. 3215-3223

  2. Standardized MRD quantification in European all trials: Proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18-20 September 2008

    Leukemia, Vol. 24, Núm. 3, pp. 521-535

2009

  1. Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients

    Leukemia, Vol. 23, Núm. 6, pp. 1106-1117

2007

  1. Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data

    Leukemia

  2. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: - Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    Leukemia, Vol. 21, Núm. 2, pp. 201-206

  3. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    Leukemia, Vol. 21, Núm. 2, pp. 207-214

2005

  1. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes

    Leukemia, Vol. 19, Núm. 11, pp. 1948-1957

2003

  1. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936

    Leukemia, Vol. 17, Núm. 12, pp. 2257-2317

  2. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - A Europe against cancer program

    Leukemia, Vol. 17, Núm. 12, pp. 2474-2486

1999

  1. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia

    Leukemia